Report Code: TIPBT00002215 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Influenza diagnostics comprises of a number of flu tests that are used to detect influenza viruses in respiratory specimens. The most common are called "rapid influenza diagnostic tests." The rapid influenza diagnostic tests work by detecting the parts of the virus (antigens) that stimulate an immune response.
The "Global Influenza Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of the influenza diagnostics market with detailed market segmentation by type, end user and geography. The report provides key statistics on the market status of the leading influenza diagnostics market players and offers key trends and opportunities in the market.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza diagnostics market in these regions.
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The global outbreak of COVID-19 has impacted all the industries.
The rising burden of infectious diseases across the globe has increased the demand for infectious disease diagnosis products, including influenza & other diseases. The recent outbreak of the coronavirus disease (COVID-19), which has emerged since December 2019 in Wuhan, China, has caused destruction in several countries across the world. According to the WHO, as of 1st June 2020, there were 6,057,853 confirmed cases and 371,166 confirmed deaths. During this pandemic, it is important to minimize the spread of the disease by early diagnosis.
When compared to influenza with COVID-19, both viruses have a similar disease presentation i.e. they both cause respiratory issues. Moreover, both are transmitted by contact, droplets, and fomites. At earlier stages, COVID-19 patients are misdiagnosed with influenza and due to which its demand has raised in late 2019. However, soon it was realized that factors such as immunity, age group, transmission rate, vaccination, & few others are drastically different in case of COVID-19 & influenza. Thus, after realizing the difference between these two infections, the demand for influenza kits was normalized and the need for a comprehensive approach for diagnosis & treatment has gained importance to combat COVID-19 pandemic.
The report covers key developments in the influenza diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from influenza diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza diagnostics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the influenza diagnostics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
The List of Companies
2. Quidel Corporation
5. F. Hoffmann-La Roche Ltd
6. Oxford Biosystems
7. Thermo Fisher Scientific
8. Meridian Bioscience
10. altona Diagnostics GmbH